Avricore Health (AVCRF) EBT Margin (2009 - 2026)
Avricore Health (AVCRF) posted quarterly EBT Margin of 544.66% for Q2 2026, up 109380.0% year-over-year from N/an in Q2 2025, and up 59.32% quarter-over-quarter from 1338.95% in Q4 2025.
Avricore Health (AVCRF) EBT Margin (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported EBT Margin for 17 consecutive years, with 544.66% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT Margin rose 109380.0% year-over-year to 544.66%; the TTM figure through Jun 2026 stood at 1065.98% (down 105754.0% YoY), while the FY2025 annual figure was 348.17%, down 33419.0% from the prior year.
- EBT Margin rose to 544.66% in Q2 2026 per AVCRF's latest filing, from 1338.95% in the prior quarter.
- Across five years, EBT Margin topped out at 13.81% in Q1 2024 and bottomed at 1638.46% in Q2 2025.
- Historically, EBT Margin has averaged 327.57% across 5 years, with a median of 31.16% in 2022.
- Annual changes were most pronounced in 2025 — EBT Margin sank 164826 bps — and 2026, when it surged 109380 bps.
- Avricore Health's EBT Margin stood at 24.21% in 2022, then jumped by 121 bps to 5.14% in 2023, then tumbled by 207 bps to 5.48% in 2024, then sank by 24312 bps to 1338.95% in 2025, then surged by 59 bps to 544.66% in 2026.
- Business Quant data shows AVCRF's EBT Margin at 544.66% in Q2 2026, 1338.95% in Q4 2025, and 1003.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | -544.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -544.66% |
| Dec 31, 2025 | -1,338.95% |
| Sep 30, 2025 | -1,003.84% |
| Jun 30, 2025 | -1,638.46% |
| Mar 31, 2025 | -17.30% |
| Sep 30, 2024 | -5.48% |
| Jun 30, 2024 | 9.80% |
| Mar 31, 2024 | 13.81% |
| Dec 31, 2023 | 5.14% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | -51.85% |
| Mar 31, 2023 | -30.72% |
| Dec 31, 2022 | -24.21% |
| Sep 30, 2022 | -31.61% |
| Jun 30, 2022 | -118.06% |
| Mar 31, 2022 | -434.88% |
| Dec 31, 2021 | -378.31% |
| Sep 30, 2021 | -42.97% |
| Jun 30, 2021 | -989.21% |
| Mar 31, 2021 | -151.82% |